MEA-ready neurons: what the phrase means and what to check instead

The short answer: “MEA-ready” is not a defined term, has no release criterion behind it, and no supplier sells neurons with a network-activity acceptance criterion attached. What you are actually buying is a frozen vial and a hope that, four to eight weeks after plating, the network fires.

That gap is where neurotech projects die. The cells are cheap and publicly priced. The instrument is commodity hardware. The maturation between them is unpriced, unspecified and entirely your risk. This page sets out what genuinely varies between products and platforms, and the four things to verify before you spend anything.

What “MEA-ready” actually means when a vendor says it

In practice it means one of four different things, and vendors rarely say which:

1. The cells are electrically active at some point after plating. True of essentially every post-mitotic neuron product sold. Not a differentiator.
2. The supplier publishes an MEA protocol. Genuinely useful, and only some do.
3. The supplier publishes MEA data on their own product. More useful still.
4. The supplier states a seeding density and an expected days-to-activity. The most useful, and the rarest.

None of those four is a guarantee. There is no certification, no standard, no threshold, and nothing you can hold a supplier to if the culture never bursts. If a vendor tells you a product is “MEA-ready”, the correct next question is “ready by what criterion, measured how, at what day”.

Platform side: what the three main systems actually are

Before matching cells to plates, the plates themselves differ in ways that change your seeding arithmetic.

The practical consequence: a 96-well Axion plate gives you eight electrodes over a 0.8 mm square, while a MaxWell well gives you 26,400 over roughly 8 mm². Those are not the same experiment. The Axion format answers “what is this population doing” at throughput. The MaxWell format answers “what is this cell doing” and can track axons. Choose the platform from the question, then choose the cells to fit the plate — not the reverse.

Compatibility matrix: cell product against platform

Published combinations only. An empty cell means the supplier does not publish that combination, not that it fails.

The four things to verify before you buy

1. Whether astrocytes are optional, and at what ratio

They are usually not optional. Every supplier in the matrix above that publishes an MEA protocol includes glia in it.

BrainXell’s protocol calls for a 2:1 to 6:1 neuron-to-astrocyte ratio. NeuCyte builds glia into the kit at a fixed 70,000 astrocytes per well against 200,000 total neurons. bit.bio publishes co-culture protocols with astrocytes and separately shows that microglia co-culture increases network correlation and mean burst duration. Ncardia publishes raster plots comparing cortical neurons with and without astrocytes and states that overall electrical activity increases in the co-culture.

Astrocyte co-culture is the single most common reason a neuronal culture that should have matured on an MEA does not. Budget for it. And note that neurons and astrocytes are often bought from different vendors with incompatible media, which nobody sells as a validated package with a stated ratio — iPSC astrocytes, microglia and glia has the published prices and the co-culture ratios side by side.

2. The seeding density in the units the plate uses

Two conventions circulate — cells per well and cells per cm² — and they translate badly between plate formats.

BrainXell states cells per well (50,000–100,000) and a 40 µL droplet, because the droplet method concentrates cells over the electrodes rather than distributing them across the well. bit.bio states a general minimum of 30,000 cells/cm². STEMCELL states 80,000 cells/cm² for a plated maturation protocol. If you convert one to the other without accounting for the droplet method, you will be wrong by a large factor, and cell density is one of the strongest determinants of whether a network bursts at all.

Ask for the number in the form the protocol uses, and ask whether it is a droplet or a distributed plating.

3. Coating

BrainXell’s protocol specifies PDL-coated plates plus Cultrex or Geltrex added to the seeding medium at a defined dilution — 10 µL of pre-diluted Cultrex per 1 mL of medium. That second step is easy to miss and it is not optional in their protocol.

Coating chemistry and coating age both matter. Poly-D-lysine, poly-ornithine and laminin are not interchangeable across protocols, and a plate coated a week ago is not a plate coated this morning. If your supplier publishes a coating protocol, follow it exactly before concluding the cells are the problem.

4. Days to bursting, and whether that fits your project

This is the number that determines your schedule, and only three suppliers publish it clearly:

• BrainXell: activity to some degree by 12 DIV, plateau around 21 DIV.
• NeuCyte: synchronised network bursting at 3–4 weeks post-seeding.
• Ricoh / Elixirgen: measured network burst firing at day 49–51 post-thaw in their published transport study, with patch clamp at 5–6 weeks post-thaw.

Take the honest reading of that spread: plan for three to seven weeks between thawing a vial and having a network worth recording from. A supplier that promises meaningful network data in days is describing cell attachment and spontaneous spiking, not synchronised bursting.

What nobody sells, and why it matters

There is no product on the market that is a delivered, already-firing human neural network on an MEA plate with a stated activity acceptance criterion.

You can buy neurons at a published price. You can buy astrocytes at a published price. You can buy an MEA and plates. What you cannot buy is the four-to-eight-week maturation with somebody else carrying the risk that it does not work. Every buyer absorbs that personally, with no recourse.

Two things make this gap narrower than it looks. First, one supplier has published a transport experiment in which a plated, active MEA plate was shipped from Tokyo to Maryland and recorded before and after — baseline network bursting at day 49 pre-transport, day 50 after a 33-hour transit, and pharmacological response to 4-AP at day 51. That is a direct demonstration that a live, active plated network survives long-haul shipping, which is the hardest-sounding part of delivering one. Second, several contract laboratories advertise customised neural culture and assay development, so the wet-work capability exists as a purchasable service even though no one packages it as a product.

That combination — live active plates demonstrably survive transport, and the culture work is contractible — is what makes a delivered MEA-ready culture brokerable rather than fictional. It is still a development engagement, not a shelf item, and we label it as such.

Practical checklist before ordering

• Which MEA platform and which plate part number, confirmed against the supplier’s protocol.
• Seeding density, in the units the protocol uses, and whether it is droplet or distributed plating.
• Coating protocol, including any matrix added to the seeding medium.
• Whether glia are required, from which supplier, at what ratio, and whether the media are compatible.
• Media schedule and how many media changes per week — this is a labour cost, not just a consumable.
• Expected day of first activity and day of plateau.
• Post-thaw viability specification and the method used to measure it.
• Whether the supplier will state any activity expectation in writing on the quote.
• Total elapsed time from order to usable data, including maturation, not just shipping.

Where to go next

For product-level availability and prices, see human iPSC-derived cortical neurons. For which suppliers publish protocols and data at all, see the supplier directory and the head-to-head comparison.

If you want a delivered active culture rather than a vial, tell us the activity criterion you would accept — burst rate, synchrony index, day of measurement — and we will source it as a contract programme against that criterion. If nobody will accept the criterion, we will tell you that too.